• Site Map
  • Search
  • Site Outline
  • Home Home
  • Company Company
    • Overview
    • Mission
    • History
    • Focus Areas
    • Patents and Trademarks
    • Management Team
    • Board of Directors
  • Technology Technology
    • Nanoparticles
    • Gold Nanoparticle Technology Overview
    • Direct Detection of Nucleic Acids
      • Chemistry
      • Applications
      • Bibliography
      • Request Information
    • Ultra-sensitive Protein Detection
      • Chemistry
      • Applications
      • Bibliography
  • Products Products
    • Verigene® System
      • Overview of the Verigene® Reader
      • Overview of the Verigene® Processor
      • Overview of a Verigene® Test Cartridge
      • Overview of the Verigene® System Workflow
    • Verigene® Nucleic Acid Tests
      • Genetics
      • Pharmacogenetics
      • Infectious diseases
      • Oncology
  • Investor Relations / Media Investor Relations / Media
    • Investor Overview
    • Stock Information
    • Corporate Governance
    • Press Releases
    • Presentations
    • Annual Reports
    • SEC Filings
    • Upcoming Events
  • Contact Us Contact Us
    • Contact Request Form
    • Careers
  • Verigene® System
    • Overview of the Verigene® Reader
    • Overview of the Verigene® Processor
    • Overview of a Verigene® Test Cartridge
    • Overview of the Verigene® System Workflow
  • Verigene® Nucleic Acid Tests
    • Genetics
      • Verigene® F5 Nucleic Acid Test (IVD)
      • Verigene® F2 Nucleic Acid Test (IVD)
      • Verigene® MTHFR Nucleic Acid Test (IVD)
      • Verigene® CFTR Nucleic Acid Test
      • Verigene® HFE Nucleic Acid Test
    • Pharmacogenetics
      • Verigene® Warfarin Metabolism Nucleic Acid Test (IVD)
    • Infectious diseases
    • Oncology
  • Verigene® System
  • Verigene® Nucleic Acid Tests
 
 
 
Nanosphere, Inc.
4088 Commercial Avenue
CoSuite
Northbrook,
IL
60062
USA
Phone: 1-888-VERIGENE (837-4436)
Fax: 847.400.9199
http://www.orbisdesign.com
E-mail:
Last Modified: 6/30/2008
245
Copyright Nanosphere, Inc. © 2008 All rights reserved worldwide.